06:58 GMT17 February 2020
Listen Live
    Asia & Pacific
    Get short URL
    374
    Subscribe

    The first delivery of humanitarian aid has been made to North Korea since the imposition of sanctions against Pyongyang following it's fourth nuclear test, carried out in January, local media reported Friday.

    TOKYO (Sputnik) — The Eugene Bell Foundation, which is helping the North combat tuberculosis, stated that despite the tensions on the Korean Peninsula, it managed to successfully deliver multi-drug-resistant tuberculosis medications and treatment supplies to North Korea, Yonhap news agency reported.

    The medications have been awaiting shipment to the North from South Korea since February, after Seoul imposed sanctions against Pyongyang, although pledging they would not affect humanitarian aid.

    According to the private aid agency, some 1,500 people in North Korea require treatment for tuberculosis.

    Tensions on the Korean Peninsula escalated after North Korea successfully carried out a hydrogen bomb test in early January and put a satellite into orbit a month later, violating UN Security Council resolutions and triggering condemnation from the international community.

    On March 2, the Security Council adopted the toughest sanctions imposed against North Korea in the past decade. The latest restrictions make all cargo going to and from the country subject to inspections and limit or prohibit the nation's export of coal, iron, gold, titanium and rare natural minerals.

    Related:

    N Korea Ready to Nuke US 'Empire of Evil' at Slightest Sign of Aggression
    Russia Against Using N Korea's Actions as Pretext for Military Buildup
    UNSC Extends North Korea Sanctions Experts' Mandate, Urges Compliance
    US Sanctions, Drills Risk N Korea Unpredictable Reaction - Peace Campaigner
    UN North Korea Probe Should Initially Focus on Defectors - Advocacy Group
    Tags:
    Democratic Republic of North Korea (DPRK), humanitarian aid
    Community standardsDiscussion
    Comment via SputnikComment via Facebook